Machine-learning screening identifies natural RORγt inhibitors with preclinical psoriasis activity
An ensemble machine-learning screen of natural products prioritized protoberberine alkaloids as candidate RORγt inhibitors. In vitro assays found that berberine and coptisine inhibited Th17 differentiation and directly bound RORγt by surface plasmon resonance; coptisine also showed efficacy in a preclinical mouse psoriasis model.
Technology: Ensemble machine-learning models for natural-product RORγt activity and counter-screening, combining graph neural networks and molecular-fingerprint random forests
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: In vitro assays found that berberine and coptisine inhibited Th17 differentiation and directly bound RORγt by surface plasmon resonance; coptisine also showed efficacy in a preclinical mouse psoriasis model.
- Still unknown: Berberine and coptisine are known natural products; the novelty is their prioritization and experimental characterization as RORγt inhibitors in this workflow, not discovery of new chemical entities. The mouse result is preclinical and does not establish psoriasis treatment in humans. The catalog already contains an unrelated RORγt result involving topotecan; this paper's compounds and evidence are distinct.
- AI role: Ensemble models screened a natural-product library and prioritized predicted RORγt inhibitors. Chemotaxonomic analysis narrowed candidates to protoberberines; six were experimentally evaluated, and berberine/coptisine showed in-vitro effects and direct target binding, with coptisine tested in a mouse psoriasis model.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13227160/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 82 of works of the same type, year and subfield (OpenAlex work metrics, 6 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.